Highly protective antimalarial antibodies via precision library generation and yeast display screening.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 21 02 2022
revised: 19 05 2022
accepted: 23 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 28 6 2022
Statut: ppublish

Résumé

The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturation mutagenesis and DNA shuffling to screen precise gene-variant yeast display libraries for improved PfCSP antigen recognition. We identified several mutations that improved recognition, predominately in framework regions, and combined these to produce a panel of antibody variants. The most improved antibody, CIS43_Var10, had three mutations and showed approximately sixfold enhanced protective potency in vivo compared to CIS43. Co-crystal and cryo-electron microscopy structures of CIS43_Var10 with the peptide epitope or with PfCSP, respectively, revealed functional roles for each of these mutations. The unbiased site-directed mutagenesis and screening pipeline described here represent a powerful approach to enhance protective potency and to enable broader clinical use of antimalarial antibodies.

Identifiants

pubmed: 35736810
pii: 213306
doi: 10.1084/jem.20220323
pmc: PMC9242090
pii:
doi:

Substances chimiques

Antibodies, Protozoan 0
Antimalarials 0
Malaria Vaccines 0
Protozoan Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI141452
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI143407
Pays : United States
Organisme : Simons Foundation
ID : SF349247
Organisme : National Resource for Automated Molecular Microscopy
Organisme : New York Structural Biology Center
Organisme : NIH HHS
ID : DP5OD023118
Pays : United States
Organisme : Departments of Chemical Engineering and Pharmaceutical Chemistry
Organisme : National Institute of Allergy and Infectious Diseases
Organisme : New York State Foundation for Science, Technology and Innovation
Organisme : Simons Electron Microscopy Center
Organisme : University of Kansas

Informations de copyright

© 2022 Banach et al.

Références

J Struct Biol. 2009 Apr;166(1):95-102
pubmed: 19263523
EMBO J. 2021 Jan 15;40(2):e105926
pubmed: 33258500
Nat Med. 2016 Dec;22(12):1456-1464
pubmed: 27820605
Nat Biotechnol. 2018 Feb;36(2):152-155
pubmed: 29309060
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33649208
Nat Med. 2014 Mar;20(3):296-300
pubmed: 24509526
Biotechnol Bioeng. 2018 Aug;115(8):1925-1937
pubmed: 29663315
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Science. 2020 Sep 4;369(6508):1261-1265
pubmed: 32753553
Cell. 2016 Sep 8;166(6):1471-1484.e18
pubmed: 27610571
PLoS Pathog. 2020 Mar 9;16(3):e1008373
pubmed: 32150583
J Mol Biol. 2020 Feb 14;432(4):1048-1063
pubmed: 31883801
Front Immunol. 2018 Aug 14;9:1876
pubmed: 30154794
Sci Adv. 2018 Oct 10;4(10):eaau8529
pubmed: 30324137
Methods Mol Biol. 2014;1131:151-81
pubmed: 24515465
Cell. 2015 Jun 18;161(7):1505-15
pubmed: 26091035
Malar J. 2019 Dec 18;18(1):426
pubmed: 31849326
Methods Enzymol. 2009;455:127-55
pubmed: 19289205
Nat Rev Immunol. 2019 Dec;19(12):761-775
pubmed: 31462718
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Nat Med. 2018 May;24(4):401-407
pubmed: 29554084
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Elife. 2016 Dec 30;5:
pubmed: 28035901
Front Immunol. 2017 May 10;8:537
pubmed: 28539926
J Struct Biol. 2009 May;166(2):205-13
pubmed: 19374019
N Engl J Med. 2021 Aug 26;385(9):803-814
pubmed: 34379916
Front Immunol. 2021 Feb 24;12:615102
pubmed: 33732238
PLoS Pathog. 2021 Dec 6;17(12):e1010133
pubmed: 34871332
Curr Opin HIV AIDS. 2019 Jul;14(4):233-239
pubmed: 31033730
Science. 2019 Dec 6;366(6470):
pubmed: 31806786
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
pubmed: 18503082
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2636-45
pubmed: 27114511
Science. 2018 Jun 22;360(6395):1358-1362
pubmed: 29880723
Nat Med. 2019 Sep;25(9):1402-1407
pubmed: 31501610
Front Immunol. 2020 Jun 30;11:1301
pubmed: 32695107
Nat Med. 2020 Jul;26(7):1135-1145
pubmed: 32451496
Sci Immunol. 2019 May 17;4(35):
pubmed: 31101672
Front Immunol. 2020 Aug 18;11:1951
pubmed: 33013848
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Curr Protoc Mol Biol. 2014 Jan 06;105:Unit 15.12.
pubmed: 24510437
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Immunity. 2020 Oct 13;53(4):733-744.e8
pubmed: 32946741
Nat Methods. 2016 Nov;13(11):928-930
pubmed: 27723752
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
pubmed: 23671333
Front Immunol. 2019 Oct 09;10:2365
pubmed: 31649674
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
Nat Med. 2018 May;24(4):408-416
pubmed: 29554083
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Immunity. 2021 Dec 14;54(12):2859-2876.e7
pubmed: 34788599
Front Immunol. 2021 May 11;12:673699
pubmed: 34046041
Cell Host Microbe. 2020 Apr 8;27(4):531-543.e6
pubmed: 32130953
Cell. 2019 Jul 25;178(3):567-584.e19
pubmed: 31348886
Protein Eng Des Sel. 2019 Sep 10;32(1):41-45
pubmed: 31297523

Auteurs

Bailey B Banach (BB)

Bioengineering Graduate Program, The University of Kansas, Lawrence, KS.

Prabhanshu Tripathi (P)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Lais Da Silva Pereira (L)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Jason Gorman (J)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Thuy Duong Nguyen (TD)

Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS.

Marlon Dillon (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Ahmed S Fahad (AS)

Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS.

Patience K Kiyuka (PK)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Bharat Madan (B)

Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS.

Jacy R Wolfe (JR)

Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS.

Brian Bonilla (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Barbara Flynn (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Joseph R Francica (JR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Nicholas K Hurlburt (NK)

Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA.

Neville K Kisalu (NK)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Tracy Liu (T)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Li Ou (L)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Reda Rawi (R)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Arne Schön (A)

Department of Biology, Johns Hopkins University, Baltimore, MD.

Chen-Hsiang Shen (CH)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

I-Ting Teng (IT)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Baoshan Zhang (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Marie Pancera (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.
Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA.

Azza H Idris (AH)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Robert A Seder (RA)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Peter D Kwong (PD)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD.

Brandon J DeKosky (BJ)

Bioengineering Graduate Program, The University of Kansas, Lawrence, KS.
Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS.
Department of Chemical Engineering, The University of Kansas, Lawrence, KS.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA.
The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH